Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allos Therapeutics, Inc.
Allos Therapeutics Selected to Join Russel 3000 Index
July 10th, 2007
Allos Therapeutics, Inc. (NASDAQ:ALTH) announced that it was selected to join the broad-market Russell 3000(R) Index. This inclusion was effective at the close of trading on June 22, 2007, when the Russell Investment Group reconstituted its set of U.S. and global equity indexes. Annual reconstitution of Russell's U.S. indexes captures the 3,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. The largest 1,000 companies in this ranking comprise the Russell 1000(R) Index and the next largest 2,000 companies become the Russell 2000(R) Index. The Russell 3000(R) Index serves as the U.S. component of the Russell Global(R) Index. Russell...
Source: Drug Law Weekly (2007-07-10)
|
|
Advertisement |
|
|
|
